Technical

Technical Analysis

DKS is trading at $225.91, rebounding sharply from its late-May 2025 lows near $167 but still well below the January 2025 all-time high of $254.60. Price sits below the 200-day SMA ($213.34) — correction: price has just crossed above the 200-day, with the 50-day ($203.87) still lagging. A death cross fired on February 17, 2026, and has not yet been reversed. The short-term momentum is strongly positive (RSI 68, MACD histogram positive for three weeks), but the intermediate structure remains bearish until the 50-day reclaims the 200-day.

Price Snapshot

Current Price

$225.91

YTD Return

12.8%

1Y Return

19.2%

52W Position %

83.8

Beta

1.24

Full Price History with 50/200 SMA

Death cross on 2026-02-17 (50-day SMA crossed below 200-day). Prior golden cross was 2025-08-25. Price is currently above the 200-day SMA ($213.34) — the first time since early March 2026 — but the 50-day ($203.87) remains well below the 200-day. This is an uptrend attempt within a larger downtrend regime.

The 23-year chart shows DKS as a secular compounder: from $13 in 2002 to a peak of $255 in January 2025. The COVID crash (March 2020) was a temporary dislocation that resolved into the strongest rally in the stock's history. The current pullback from all-time highs is the deepest since the 2022 selloff but follows a similar pattern of testing and then bouncing off the $170–180 support zone.

Relative Strength vs Benchmarks

Benchmark ETF data (SPY, XLY) not available in the current data set. Relative performance analysis is limited to DKS absolute returns. Based on reported returns: DKS +19.2% over the past year and +172.6% over five years — substantially ahead of broad-market returns over both windows, suggesting sustained outperformance against Consumer Discretionary peers.

Momentum — RSI and MACD

RSI at 67.8 — approaching overbought but not there yet. MACD histogram has been positive and widening since early April 2026, confirming the current rally has momentum behind it. This is the strongest MACD signal since the July 2025 bounce. Near-term (1–3 months): momentum is bullish, though RSI is getting extended and a pullback to the 55–60 zone would be healthy.

Volume and Conviction

No Results

The current rally from the April lows has been on modestly elevated volume, but nothing exceptional. The highest-volume days in DKS history are all earnings-driven: the stock moves 10–25% on results, then reverts to quieter trading. The recent April recovery has not yet produced a conviction-level volume spike — the trend is improving but not yet confirmed by institutional accumulation.

Volatility Regime

Current 30-day realized volatility is 30.8%, sitting in the "normal" band (p20=24.4%, p80=49.5%). This is well below the stress spikes seen in August 2023 (84%) and April 2025 (58%). The market is not pricing in elevated risk for DKS right now — vol has compressed as the stock has rallied. If anything, the calm vol environment supports the current bounce continuing, but also means a vol expansion (likely earnings-driven) could be sharp when it comes.

Technical Scorecard

No Results

Stance — Neutral on a 3–6 month horizon. The short-term momentum is undeniably bullish: RSI rising, MACD positive, price reclaiming the 200-day. But the structural picture is still bearish — a death cross is active, the 50-day SMA is 10 points below the 200-day, and the rally from the May–June lows hasn't been confirmed by volume. DKS is a stock that moves 10–25% on a single earnings print; the next report will resolve the ambiguity. Above $237 (52-week high) confirms the downtrend is over and the stock is resuming its secular uptrend — that's the bullish trigger. Below $185 (April 2026 lows) would signal the rally was a dead-cat bounce and the trend lower continues toward $167 support.